Get started
Author

Giulia Gobbi

Observed names: G. Gobbi, Gobbi, Giulia
ORCID: 0009-0003-2412-8674
Observed ORCID: 0009-0003-2412-8674
OpenAlex ID: A5060017642
YAP and TAZ Are Not Identical Twins
2020 · Francesca Reggiani, Giulia Gobbi, et al. · Trends in Biochemical Sciences · 162
RUNX2 expression in thyroid and breast cancer requires the cooperation of three non-redundant enhancers under the control of BRD4 and c-JUN
2017 · Valentina Sancisi, Gloria Manzotti, et al. · Nucleic Acids Research · 75
PDF
The Hippo pathway modulates resistance to BET proteins inhibitors in lung cancer cells
2019 · Giulia Gobbi, Benedetta Donati, et al. · Oncogene · 71
The multifaceted role of EGLN family prolyl hydroxylases in cancer: going beyond HIF regulation
2022 · Silvia Strocchi, Francesca Reggiani, et al. · Oncogene · 59
Multiple roles and context-specific mechanisms underlying YAP and TAZ-mediated resistance to anti-cancer therapy
2020 · Francesca Reggiani, Giulia Gobbi, et al. · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 33
RAIN Is a Novel Enhancer-Associated lncRNA That Controls RUNX2 Expression and Promotes Breast and Thyroid Cancer
2019 · Teresa Rossi, Mariaelena Pistoni, et al. · Molecular Cancer Research · 28
BET inhibitors drive Natural Killer activation in non-small cell lung cancer via BRD4 and SMAD3
2024 · Francesca Reggiani, Giovanna Talarico, et al. · Nature Communications · 24
PDF
An integrative functional genomics approach reveals EGLN1 as a novel therapeutic target in KRAS mutated lung adenocarcinoma
2021 · Francesca Reggiani, Elisabetta Sauta, et al. · Molecular Cancer · 18
PDF
CSNK1A1, KDM2A, and LTB4R2 Are New Druggable Vulnerabilities in Lung Cancer
2021 · Elisabetta Sauta, Francesca Reggiani, et al. · Cancers · 12
PDF
The long non-coding RNA TAZ-AS202 promotes lung cancer progression via regulation of the E2F1 transcription factor and activation of Ephrin signaling
2023 · Giulia Gobbi, Alessandra Grieco, et al. · Cell Death and Disease · 10
PDF
Radical-induced autoxidation dominates squalene oxidative aging under environmental conditions
2026 · Xinke Wang, Jillian P. Downey, et al. · Science Advances
El ser humano entre técnica y sobrenaturaleza
2026 · Gobbi, Giulia · Etica-Mente, L'Annuario
PDF
Data from RAIN Is a Novel Enhancer-Associated lncRNA That Controls RUNX2 Expression and Promotes Breast and Thyroid Cancer
2023 · Teresa Rossi, Mariaelena Pistoni, et al.
Supplementary Figures, Tables and Materials and Methods from RAIN Is a Novel Enhancer-Associated lncRNA That Controls RUNX2 Expression and Promotes Breast and Thyroid Cancer
2023 · Teresa Rossi, Mariaelena Pistoni, et al.
PDF
Data from RAIN Is a Novel Enhancer-Associated lncRNA That Controls RUNX2 Expression and Promotes Breast and Thyroid Cancer
2023 · Teresa Rossi, Mariaelena Pistoni, et al.
EP16.03-042 BET Inhibitors Stimulate NK Cytotoxic Activity in NSCLC through Attenuation of YAP/TAZ and SMAD3 Transcriptional Programs
2022 · F. Reggiani, S. Orecchioni, et al. · Journal of Thoracic Oncology
The speaking body in digital communication based on the reflections of Ortega y Gasset
2021 · Gobbi, Giulia · Scenari
PDF
TAZ role in lung cancer: resistance to BET inhibitors and functional interaction with lncRNA
2021 · Gobbi, Giulia · AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna)
PDF
Abstract B33: Genome-scale CRISPR/Cas9 screening identifies Hippo pathway as key determinant for susceptibility to BET inhibitors in lung cancer
2020 · Giulia Gobbi, Benedetta Donati, et al. · Molecular Cancer Research
Abstract B18: YAP1 and TAZ mediate BET inhibitor-dependent immune regulation in NSCLC
2020 · Francesca Reggiani, Giulia Gobbi, et al. · Molecular Cancer Research
A13 A Functional Genomics Approach Highlights New Therapeutic Opportunities for KRAS-Mutated Non-Small Cell Lung Cancer
2020 · F. Reggiani, E. Sauta, et al. · Journal of Thoracic Oncology
Works count: 21
Citation count: 492
H-index: 10
I10-index: 10
Year
Topic
Type